Inhibrx, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 78.71 million compared to USD 48.92 million a year ago. Basic loss per share from continuing operations was USD 1.44 compared to USD 1.12 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.24 USD | -0.48% | -0.75% | -9.92% |
May. 09 | Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 28 | Inhibrx Shares Fall After Q4 Net Loss Widens | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.92% | 1.8B | |
+10.42% | 115B | |
+12.02% | 106B | |
-5.87% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.53% | 17.56B | |
-40.50% | 17.32B | |
+6.46% | 14.03B | |
+30.93% | 12.13B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024